Grant Comer MD
Retinal Disease
Associate Professor, University of Michigan Kellogg Eye Center
Join to View Full Profile
1000 Wall StreetAnn Arbor, MI 48105
Phone+1 734-763-5874
Fax+1 734-232-0865
Dr. Comer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Grant Comer is a retina specialist who sees patients at the University of Michigan Kellogg Eye Center’s offices in Ann Arbor and Brighton. His clinical practice focuses on the medical and surgical management of the retina and vitreous, including diagnosis and treatment of ocular melanoma, retinal detachments, diabetic retinopathy, age-related macular degeneration, retinal vascular disease, ocular trauma, and infectious chorioretinitis.
Dr. Comer’s research interests include the diagnosis and management of infectious chorioretinitis with particular focus on drug-resistant organisms and how they relate to ocular disease. To make an appointment, please call Kellogg’s Retina and Uveitis Clinic at 734-763-5874 or Kellogg’s Brighton office at 810-227-2357. To refer a patient, please visit www.kellogg.umich.edu/refer.
Education & Training
University of Michigan, Rackham Graduate SchoolM.Sc., Clinical Research Design and Statistical Analysis, 2007 - 2009
Indiana University School of MedicineResidency, Ophthalmology, 2002 - 2005- Indiana University School of Medicine/Methodist HospitalInternship, Transitional Year, 2001 - 2002
- Indiana University School of MedicineClass of 2001
- Wabash CollegeA.B., Biology, Magna Cum Laude, 1993 - 1997
Certifications & Licensure
MI State Medical License 2005 - 2027
American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification Outgoing Public Health Reporting from EpicCare Functionality, Epic Systems Corporation, 2013-2014, 2016-2017
Clinical Trials
- Efficacy and Safety Study of MC-1101 1% TID in the Treatment of Nonexudative Age-Related Macular Degeneration Start of enrollment: 2012 Oct 01
- Treatment for CI-DME in Eyes With Very Good VA Study Start of enrollment: 2013 Oct 01
- A Phase 2 Multicenter Randomized Clinical Trial of CNTF for MacTel Start of enrollment: 2014 Apr 01
Publications & Presentations
PubMed
- 5 citationsSevere Spontaneous Tilt of Scleral-Fixated Intraocular Lenses.Jennifer M Enright, Boonkit Purt, Brent Bruck, Parth Shah, Emily Eton
American Journal of Ophthalmology. 2024-06-01 - 8 citationsIntraretinal pigmented cells in retinal degenerative disease.Marina Yasvoina, Qian Yang, Sasha M Woods, Tjebo Heeren, Grant M Comer
The British Journal of Ophthalmology. 2023-11-01 - 25 citationsNovel TMEM98, MFRP, PRSS56 variants in a large United States high hyperopia and nanophthalmos cohort.Lev Prasov, Bin Guan, Ehsan Ullah, Steven M. Archer, Bernadete Ayres
Scientific Reports. 2020-11-17
Journal Articles
- Medical Characteristics of Patients with Macular Telangiectasia Type 2 (MacTel Type 2) MacTel Project Report No 3Clemons TE, Gillies MC, Chew EY, Bird AC, Peto T, Wang JJ, Mitchell P, Ramdas WD, Vingerling JR, Macular Telangiectasia Project Research Group, Ophthalmic Epidemiology, 1/1/2013
- En face OCT Imaging of the IS/OS Junction Line in Type 2 Idiopathic Macular TelangiectasiaSallo FB, Peto T, Egan C, Wolf-Schnurrbusch UEK, Clemons TE, Gillies MC, Pauleikhoff D, Rubin GS, Chew EY, Bird AC, MacTel Study Group, Investigative Ophthalmology and Visual Science, 1/1/2012
- Identifiction of a Potential Susceptibility Locus for Macular Telangiectasia Type 2Parmalee NL, Schubert C, Figueroa M, Bird AC, Peto T, Gillies MC, Bernstein PS, Kiryluk K, Terwilliger JD, Allikmets R, MacTel Study Group, PLoS ONE, 1/1/2012
Professional Memberships
- Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
